Business Context and Reporting Period
This Form 8-K, dated May 22, 2026, serves as a supplement to the definitive proxy statement for Range Capital Acquisition Corp. (RANG), a Cayman Islands-based special purpose acquisition company (SPAC). The filing details a proposed amendment to the Company's charter to extend the deadline for consummating an initial business combination. The Company's IPO was consummated on December 23, 2024, and an Extraordinary General Meeting is scheduled for June 18, 2026, to vote on this proposal.
Key Financial Metrics
- Trust Account Balance: Approximately $122,173,834.12 as of May 21, 2026.
- Estimated Redemption Price: Approximately $10.62 per Public Share (before taxes).
- Market Price: $10.62 per share (NASDAQ closing price on May 21, 2026).
- Liquidation Expense Cap: Reduced from $100,000 to $20,000 (deductible from interest earned in the Trust Account).
- Extension Funding: Sponsor to deposit $0.03 per public share per month, capped at $60,000 per month, in exchange for a non-interest bearing promissory note.
Material Changes Versus Prior Period
The filing amends the terms previously disclosed in the definitive proxy statement regarding the extension of the business combination deadline:
- Extension Duration: The proposed extension period has been modified from a fixed 24-month term to a flexible term of up to 27 months from the IPO closing (March 23, 2027). This allows for monthly extensions of up to nine months beyond the original 18-month Termination Date (June 23, 2026).
- Extension Mechanics: The Company will seek shareholder approval to extend the deadline on a monthly basis, contingent upon the Sponsor depositing funds into the Trust Account for each month.
- Expense Reduction: The maximum amount of interest earnings available to pay for liquidation and dissolution expenses has been reduced from $100,000 to $20,000.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors believes the extension is in the best interests of the Company to allow more time to evaluate, negotiate, and consummate an initial business combination. If shareholders approve the amendment and do not redeem their shares, they retain voting rights on future business combinations.
Risks and Contingencies:
- Shareholder Approval: The extension is contingent upon the receipt of requisite stockholder approval at the Extraordinary General Meeting.
- Liquidity Risk: The Company notes that shareholders may not be able to sell shares in the open market even if the market price exceeds the redemption price due to potential lack of liquidity.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks and uncertainties that could cause actual results to differ from estimates, including the estimated redemption price and timing.
Investor Verification Checklist
- Verify the outcome of the Extraordinary General Meeting scheduled for June 18, 2026, regarding the Extension Amendment Proposal.
- Confirm the final number of Public Shares outstanding following any redemptions to calculate the exact Sponsor deposit required for monthly extensions.
- Monitor future Form 8-K filings within four business days of each monthly contribution to the Trust Account.
- Review the definitive proxy statement in its entirety for full details on the redemption process and voting procedures.